Search

Olga V. Tcherkasskaya

Examiner (ID: 5403, Phone: (571)270-3672 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1615
Total Applications
928
Issued Applications
461
Pending Applications
124
Abandoned Applications
380

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19316693 [patent_doc_number] => 20240238233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => Pharmaceutical Composition and Method for Improving Biomechanical Integrity of the Pelvic Floor [patent_app_type] => utility [patent_app_number] => 18/411193 [patent_app_country] => US [patent_app_date] => 2024-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9039 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18411193 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/411193
Pharmaceutical Composition and Method for Improving Biomechanical Integrity of the Pelvic Floor Jan 11, 2024 Pending
Array ( [id] => 19111152 [patent_doc_number] => 20240122902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS [patent_app_type] => utility [patent_app_number] => 18/391451 [patent_app_country] => US [patent_app_date] => 2023-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14138 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18391451 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/391451
Treatment of idiopathic pulmonary fibrosis Dec 19, 2023 Issued
Array ( [id] => 19125643 [patent_doc_number] => 20240130996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-25 [patent_title] => PHARMACEUTICAL COMPOSITIONS AND PHARMACOKINETICS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE [patent_app_type] => utility [patent_app_number] => 18/533982 [patent_app_country] => US [patent_app_date] => 2023-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15265 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18533982 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/533982
PHARMACEUTICAL COMPOSITIONS AND PHARMACOKINETICS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE Dec 7, 2023 Pending
Array ( [id] => 19700039 [patent_doc_number] => 12194037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-14 [patent_title] => Apparatus, methods, and systems for providing pharmaceutical compositions and administering medications to patients [patent_app_type] => utility [patent_app_number] => 18/529978 [patent_app_country] => US [patent_app_date] => 2023-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 102 [patent_no_of_words] => 39313 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18529978 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/529978
Apparatus, methods, and systems for providing pharmaceutical compositions and administering medications to patients Dec 4, 2023 Issued
Array ( [id] => 19049239 [patent_doc_number] => 20240091208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING VENGLUSTAT [patent_app_type] => utility [patent_app_number] => 18/515897 [patent_app_country] => US [patent_app_date] => 2023-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12805 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18515897 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/515897
PHARMACEUTICAL COMPOSITIONS COMPRISING VENGLUSTAT Nov 20, 2023 Pending
Array ( [id] => 19081803 [patent_doc_number] => 20240108604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-04 [patent_title] => TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS [patent_app_type] => utility [patent_app_number] => 18/513181 [patent_app_country] => US [patent_app_date] => 2023-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14109 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18513181 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/513181
Treatment of idiopathic pulmonary fibrosis Nov 16, 2023 Issued
Array ( [id] => 19032444 [patent_doc_number] => 20240082259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => QUETIAPINE ORAL LIQUID SUSPENSION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/507884 [patent_app_country] => US [patent_app_date] => 2023-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14992 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18507884 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/507884
QUETIAPINE ORAL LIQUID SUSPENSION AND USE THEREOF Nov 12, 2023 Pending
Array ( [id] => 19032444 [patent_doc_number] => 20240082259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => QUETIAPINE ORAL LIQUID SUSPENSION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/507884 [patent_app_country] => US [patent_app_date] => 2023-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14992 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18507884 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/507884
QUETIAPINE ORAL LIQUID SUSPENSION AND USE THEREOF Nov 12, 2023 Pending
Array ( [id] => 19170870 [patent_doc_number] => 20240156844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => ORALLY ADMINISTRABLE FORMULATION [patent_app_type] => utility [patent_app_number] => 18/506793 [patent_app_country] => US [patent_app_date] => 2023-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18506793 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/506793
ORALLY ADMINISTRABLE FORMULATION Nov 9, 2023 Pending
Array ( [id] => 19140333 [patent_doc_number] => 20240139109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => PHARMACEUTICAL FORMULATIONS [patent_app_type] => utility [patent_app_number] => 18/501714 [patent_app_country] => US [patent_app_date] => 2023-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24424 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18501714 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/501714
PHARMACEUTICAL FORMULATIONS Nov 2, 2023 Pending
Array ( [id] => 19140333 [patent_doc_number] => 20240139109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => PHARMACEUTICAL FORMULATIONS [patent_app_type] => utility [patent_app_number] => 18/501714 [patent_app_country] => US [patent_app_date] => 2023-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24424 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18501714 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/501714
PHARMACEUTICAL FORMULATIONS Nov 2, 2023 Pending
Array ( [id] => 19018806 [patent_doc_number] => 20240074977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => LYOPHILIZED FORMULATIONS OF TEGAVIVINT [patent_app_type] => utility [patent_app_number] => 18/383389 [patent_app_country] => US [patent_app_date] => 2023-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9202 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18383389 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/383389
Lyophilized formulations of tegavivint Oct 23, 2023 Issued
Array ( [id] => 19065800 [patent_doc_number] => 20240100226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => WATER-SOLUBLE SALT PARTICLE CONTAINING COMPOSITIONS AND POROUS MATERIALS MADE THEREFROM [patent_app_type] => utility [patent_app_number] => 18/380350 [patent_app_country] => US [patent_app_date] => 2023-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13090 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18380350 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/380350
WATER-SOLUBLE SALT PARTICLE CONTAINING COMPOSITIONS AND POROUS MATERIALS MADE THEREFROM Oct 15, 2023 Pending
Array ( [id] => 19921791 [patent_doc_number] => 12296050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-13 [patent_title] => Pharmaceutical compositions comprising maralixibat and uses thereof [patent_app_type] => utility [patent_app_number] => 18/377216 [patent_app_country] => US [patent_app_date] => 2023-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 39 [patent_no_of_words] => 37446 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18377216 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/377216
Pharmaceutical compositions comprising maralixibat and uses thereof Oct 4, 2023 Issued
Array ( [id] => 18901267 [patent_doc_number] => 20240016752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => POLYMERIZED WHEY PROTEIN ENCAPSULATED ANTIOXIDANT COMPOUND AND A PROCESS FOR PREPARATION OF SAME [patent_app_type] => utility [patent_app_number] => 18/474553 [patent_app_country] => US [patent_app_date] => 2023-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9433 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18474553 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/474553
Polymerized whey protein encapsulated antioxidant compound and a process for preparation of same Sep 25, 2023 Issued
Array ( [id] => 19049180 [patent_doc_number] => 20240091149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING GASTROINTESTINAL ABSORPTION OF ELECTROLYTES [patent_app_type] => utility [patent_app_number] => 18/469299 [patent_app_country] => US [patent_app_date] => 2023-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5457 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18469299 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/469299
COMPOSITIONS AND METHODS FOR IMPROVING GASTROINTESTINAL ABSORPTION OF ELECTROLYTES Sep 17, 2023 Pending
Array ( [id] => 18829125 [patent_doc_number] => 20230397647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-14 [patent_title] => CHEWABLE DISSOLVABLE NICOTINE TABLET [patent_app_type] => utility [patent_app_number] => 18/456763 [patent_app_country] => US [patent_app_date] => 2023-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9733 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18456763 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/456763
CHEWABLE DISSOLVABLE NICOTINE TABLET Aug 27, 2023 Pending
Array ( [id] => 18829125 [patent_doc_number] => 20230397647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-14 [patent_title] => CHEWABLE DISSOLVABLE NICOTINE TABLET [patent_app_type] => utility [patent_app_number] => 18/456763 [patent_app_country] => US [patent_app_date] => 2023-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9733 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18456763 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/456763
CHEWABLE DISSOLVABLE NICOTINE TABLET Aug 27, 2023 Pending
Array ( [id] => 18841728 [patent_doc_number] => 20230404131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => DISSOLVABLE-CHEWABLE EXHAUSTED-TOBACCO TABLET [patent_app_type] => utility [patent_app_number] => 18/455799 [patent_app_country] => US [patent_app_date] => 2023-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10421 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455799 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/455799
DISSOLVABLE-CHEWABLE EXHAUSTED-TOBACCO TABLET Aug 24, 2023 Pending
Array ( [id] => 18841728 [patent_doc_number] => 20230404131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => DISSOLVABLE-CHEWABLE EXHAUSTED-TOBACCO TABLET [patent_app_type] => utility [patent_app_number] => 18/455799 [patent_app_country] => US [patent_app_date] => 2023-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10421 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455799 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/455799
DISSOLVABLE-CHEWABLE EXHAUSTED-TOBACCO TABLET Aug 24, 2023 Pending
Menu